Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an increasing incidence. Despite the fact that systematic chemotherapy with a doxorubicin provides only marginal improvements in survival of the HCC patients, the doxorubicin is being used in transarterial therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Korga, Agnieszka, Ostrowska, Marta, Jozefczyk, Aleksandra, Iwan, Magdalena, Wojcik, Rafal, Zgorka, Grazyna, Herbet, Mariola, Vilarrubla, Gemma Gomez, Dudka, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499973/
https://www.ncbi.nlm.nih.gov/pubmed/31053173
http://dx.doi.org/10.1186/s40360-019-0301-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499973/
https://www.ncbi.nlm.nih.gov/pubmed/31053173
http://dx.doi.org/10.1186/s40360-019-0301-2

Ejemplares similares